| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.22 | 8e-05 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.21 | 0.0002 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |